Published: Sep 04, 2026, 13:05 IST | Updated: Sep 04, 2026, 13:05 IST
New Zealand has approved pharmaceutical-grade MDMA for use by two psychiatrists treating people with severe PTSD. The decision by Medsafe makes New Zealand only the second country after Australia to approve MDMA for PTSD treatment.